Status:

UNKNOWN

Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

Lead Sponsor:

National Hospital Organization Kinki-chuo Chest Medical Center

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

RATIONALE: Studying quality-of-life in patients undergoing cancer treatment may help identify the intermediate and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial...

Detailed Description

OBJECTIVES: * Compare the quality of life of patients with advanced non-small cell lung cancer treated with vinorelbine, gemcitabine, and docetaxel vs paclitaxel and carboplatin on protocol JMTO-LC00...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically or cytologically confirmed primary non-small cell lung cancer, including any of the following:
  • Newly diagnosed selected stage IIIB (T4 lesion due to malignant pleural effusion) disease
  • Newly diagnosed stage IV disease
  • Recurrent disease after prior surgery and/or radiotherapy
  • Any of the following cellular subtypes are allowed:
  • Adenocarcinoma
  • Large cell carcinoma
  • Squamous cell carcinoma
  • Unspecified carcinoma
  • Enrolled on protocol JMTO-LC00-03
  • PATIENT CHARACTERISTICS:
  • Performance status
  • Zubrod 0-1
  • Life expectancy
  • Not specified
  • Hematopoietic
  • Not specified
  • Hepatic
  • Not specified
  • Renal
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • Radiotherapy
  • See Disease Characteristics
  • Surgery
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    April 1 2004

    Trial Type :

    OBSERVATIONAL

    End Date :

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00242983

    Start Date

    April 1 2004

    Last Update

    December 18 2013

    Active Locations (21)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 6 (21 locations)

    1

    Toyohashi Municipal Hospital

    Aichi, Japan, 466-8560

    2

    Ichinomiyanishi Hospital

    Aichi, Japan, 491-0201

    3

    Asahikawa Medical College

    Asahikawa, Japan, 078 8510

    4

    National Cancer Center Hospital East

    Chiba-ken, Japan, 277-8577

    Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer | DecenTrialz